Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2361

1.

Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.

Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, Perdomo C, Schaffer M, Liu G, Zhang S, Liu H, Vick J, Dhillon SS, Platero SJ, Dubinett SM, Stevenson C, Reid ME, Lenburg ME, Spira AE.

Nat Commun. 2019 Apr 23;10(1):1856. doi: 10.1038/s41467-019-09834-2.

PMID:
31015447
2.

Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.

Zhang Y, Jiang WL, Yang JY, Huang J, Kang G, Hu HB, Xie S.

J Cell Physiol. 2019 Apr 16. doi: 10.1002/jcp.28508. [Epub ahead of print]

PMID:
30993701
3.

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis.

Hossian AKMN, Muthumula CMR, Sajib MS, Tullar PE, Stelly AM, Briski KP, Mikelis CM, Matthaiolampakis G.

J Vis Exp. 2019 Mar 30;(145). doi: 10.3791/59460.

PMID:
30985742
4.

The landscape of actionable molecular alterations in immunomarker-defined large cell carcinoma of lung.

Chan AW, Chau SL, Tong JH, Chow C, Kwan JS, Chung LY, Lung RW, Tong CY, Tin EK, Law PP, Law WT, Ng CS, Wan IY, Mok TS, To KF.

J Thorac Oncol. 2019 Apr 9. pii: S1556-0864(19)30277-1. doi: 10.1016/j.jtho.2019.03.021. [Epub ahead of print]

PMID:
30978501
5.

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer.

Liao Y, Guo Z, Xia X, Liu Y, Huang C, Jiang L, Wang X, Liu J, Huang H.

J Exp Clin Cancer Res. 2019 Apr 11;38(1):157. doi: 10.1186/s13046-019-1165-4.

6.

Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma.

Liu S, Han Z, Trivett AL, Lin H, Hannifin S, Yang, Oppenheim JJ.

Cancer Immunol Immunother. 2019 Apr 10. doi: 10.1007/s00262-019-02326-8. [Epub ahead of print]

PMID:
30972427
7.

Lentiviral delivery of a shRNA sequence analogous to miR-4319/miR-125-5p induces apoptosis in NSCLC cells by arresting G2/M phase.

Xu X, Lai Y, Zhou W, Hua Z.

J Cell Biochem. 2019 Apr 7. doi: 10.1002/jcb.28676. [Epub ahead of print]

PMID:
30957262
8.

Sequence-dependent synergistic cytotoxicity of icotinib and pemetrexed in human lung cancer cell lines in vitro and in vivo.

Liu T, Jin L, Lu W, Gan H, Lin Z, Chen M, Liu J, Zhang F, Wang S, Zhang H, Deng W, Chen H.

J Exp Clin Cancer Res. 2019 Apr 5;38(1):148. doi: 10.1186/s13046-019-1133-z.

9.

AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.

Zhang M, Jin C, Yang Y, Wang K, Zhou Y, Zhou Y, Wang R, Li T, Hu R.

J Cell Physiol. 2019 Apr 5. doi: 10.1002/jcp.28617. [Epub ahead of print]

PMID:
30953357
10.

Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.

Liu Z, Xu S, Li L, Zhong X, Chen C, Fan Y, Shen W, Zu L, Xue F, Wang M, Zhou Q.

Thorac Cancer. 2019 Apr 4. doi: 10.1111/1759-7714.13052. [Epub ahead of print]

PMID:
30950202
11.

Epigenetic Changes in Alveolar Type II Lung Cells of A/J Mice Following Intranasal Treatment with Lipopolysaccharide.

Seiler CL, Song JM, Fernandez J, Abrahante JE, Kono TJY, Chen Y, Ren Y, Kassie F, Tretyakova NY.

Chem Res Toxicol. 2019 Apr 16. doi: 10.1021/acs.chemrestox.9b00015. [Epub ahead of print]

PMID:
30942577
13.

PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.

Mao S, Li Y, Lu Z, Che Y, Huang J, Lei Y, Wang Y, Liu C, Wang X, Zheng S, Sun N, He J.

Cancer Med. 2019 Apr 1. doi: 10.1002/cam4.2115. [Epub ahead of print]

14.

Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.

Yu N, Yong S, Kim HK, Choi YL, Jung Y, Kim D, Seo J, Lee YE, Baek D, Lee J, Lee S, Lee JE, Kim J, Kim J, Lee S.

Mol Oncol. 2019 Mar 26. doi: 10.1002/1878-0261.12478. [Epub ahead of print]

15.

Reciprocal interaction of HOTAIR and SP1 together enhance the ability of Xiaoji decoction and gefitinib to inhibit EP4 expression.

Wu J, Tang Q, Ren X, Zheng F, He C, Chai X, Li L, Hann SS.

J Ethnopharmacol. 2019 Mar 22;237:128-140. doi: 10.1016/j.jep.2019.03.027. [Epub ahead of print]

PMID:
30910577
16.

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.

Exposito F, Villalba M, Redrado M, de Aberasturi AL, Cirauqui C, Redin E, Guruceaga E, de Andrea C, Vicent S, Ajona D, Montuenga LM, Pio R, Calvo A.

Cancer Lett. 2019 Jul 1;453:21-33. doi: 10.1016/j.canlet.2019.03.013. Epub 2019 Mar 21.

PMID:
30905815
17.

Potential Oncogenic Role of the Papillary Renal Cell Carcinoma Gene in Non-Small Cell Lung Cancers.

Jang SH, Jiang Y, Shin S, Jung SH, Jung CK, Chung YJ.

Yonsei Med J. 2019 Apr;60(4):326-335. doi: 10.3349/ymj.2019.60.4.326.

18.

Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.

Lu J, Gu X, Liu F, Rui Z, Liu M, Zhao L.

Oncol Rep. 2019 May;41(5):2987-2996. doi: 10.3892/or.2019.7084. Epub 2019 Mar 21.

PMID:
30896844
19.

Gene Expression Profiling Revealed 2 Types of Bronchial Basal Cell Hyperplasia and Squamous Metaplasia With Different Progression Potentials.

Denisov EV, Schegoleva AA, Gerashchenko TS, Skryabin NA, Sleptcov AA, Yakushina VD, Lyapunova LS, Tuzikov SA, Pankova OV, Perelmuter VM.

Appl Immunohistochem Mol Morphol. 2019 Mar 20. doi: 10.1097/PAI.0000000000000762. [Epub ahead of print]

PMID:
30896548
20.

Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells.

Buendia Duque M, Pinheiro KV, Thomaz A, da Silva CA, Freire NH, Brunetto AT, Schwartsmann G, Jaeger M, de Farias CB, Roesler R.

J Mol Neurosci. 2019 May;68(1):49-57. doi: 10.1007/s12031-019-01280-5. Epub 2019 Mar 18.

PMID:
30887411

Supplemental Content

Loading ...
Support Center